Additionally, ovarian cancer cell stemness is reduced by the FK506-binding protein like (FKBPL) peptide via inhibiting the CD44/STAT3 signaling axis (241) and the medicinal herb corilagin sensitizes human ovarian cancer cell lines to chemotherapy by glycolysis inhibition via downregulation of both CD44 and STAT3 expression (242). This evidence concerns the gene CD44 and ovarian cancer.